This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1999 Jan;20(1):3-9.

doi: 10.1016/S0893-133X(98)00061-X.

Molecular genetics of substance abuse vulnerability: a current approach

G R Uhl¹

Affiliations

PMID: 9885780
DOI: 10.1016/S0893-133X(98)00061-X

Free article

Review

Molecular genetics of substance abuse vulnerability: a current approach

G R Uhl. Neuropsychopharmacology. 1999 Jan.

Free article

. 1999 Jan;20(1):3-9.

doi: 10.1016/S0893-133X(98)00061-X.

Author

G R Uhl¹

Affiliation

¹ Molecular Neurobiology Branch, National Institute on Drug Abuse, NIH, Baltimore, MD, USA.

PMID: 9885780
DOI: 10.1016/S0893-133X(98)00061-X

No abstract available

PubMed Disclaimer

Similar articles

Psychogenomics: opportunities for understanding addiction.
Nestler EJ. Nestler EJ. J Neurosci. 2001 Nov 1;21(21):8324-7. doi: 10.1523/JNEUROSCI.21-21-08324.2001. J Neurosci. 2001. PMID: 11606619 Free PMC article. Review.
Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results.
Uhl GR. Uhl GR. Ann N Y Acad Sci. 2004 Oct;1025:1-13. doi: 10.1196/annals.1316.001. Ann N Y Acad Sci. 2004. PMID: 15542694 Review.
Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence.
Covault J, Gelernter J, Kranzler H. Covault J, et al. Mol Psychiatry. 2001 Sep;6(5):501-2. doi: 10.1038/sj.mp.4000925. Mol Psychiatry. 2001. PMID: 11526463 No abstract available.
Genetics as a tool for identifying biological markers of drug abuse.
Collins AC. Collins AC. NIDA Res Monogr. 1986;66:57-70. NIDA Res Monogr. 1986. PMID: 3106818 No abstract available.
Genetic markers of drug abuse in mouse models.
Shuster L. Shuster L. NIDA Res Monogr. 1986;66:71-85. NIDA Res Monogr. 1986. PMID: 3106819 No abstract available.

See all similar articles

Cited by

What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?
Cumming P, Caprioli D, Dalley JW. Cumming P, et al. Br J Pharmacol. 2011 Aug;163(8):1586-604. doi: 10.1111/j.1476-5381.2010.01036.x. Br J Pharmacol. 2011. PMID: 20846139 Free PMC article. Review.
A review of pharmacogenetic studies of substance-related disorders.
Jones JD, Comer SD. Jones JD, et al. Drug Alcohol Depend. 2015 Jul 1;152:1-14. doi: 10.1016/j.drugalcdep.2015.03.003. Epub 2015 Mar 18. Drug Alcohol Depend. 2015. PMID: 25819021 Free PMC article. Review.
Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.
Alcaro A, Huber R, Panksepp J. Alcaro A, et al. Brain Res Rev. 2007 Dec;56(2):283-321. doi: 10.1016/j.brainresrev.2007.07.014. Epub 2007 Aug 21. Brain Res Rev. 2007. PMID: 17905440 Free PMC article. Review.
Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.
Uhl GR, Liu QR, Walther D, Hess J, Naiman D. Uhl GR, et al. Am J Hum Genet. 2001 Dec;69(6):1290-300. doi: 10.1086/324467. Epub 2001 Nov 6. Am J Hum Genet. 2001. PMID: 11704927 Free PMC article.
Needed: mouse/human cross validation of reinstatement/relapse models (and drug reward models) to model human substance abuse vulnerability allelic variants.
Uhl GR. Uhl GR. Psychopharmacology (Berl). 2003 Jul;168(1-2):42-43. doi: 10.1007/s00213-003-1499-6. Epub 2003 Apr 29. Psychopharmacology (Berl). 2003. PMID: 12719965 No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical